paclitaxel has been researched along with Hyperlipidemias in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ako, J; Fitzgerald, PJ; Hasegawa, T; Honda, Y; Otake, H; Sakurai, R; Shimohama, T; Tsujino, I; Waseda, K; Yamasaki, M | 1 |
1 trial(s) available for paclitaxel and Hyperlipidemias
| Article | Year |
|---|---|
Vascular response to overlapping everolimus-eluting stents. - Comparison with paclitaxel-eluting stents -.
Topics: Aged; Antineoplastic Agents, Phytogenic; Diabetes Mellitus; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Retrospective Studies; Sirolimus; Ultrasonography, Interventional | 2010 |